Lee Ainslie’s ANI Pharmaceuticals ANIP Stock Holding History

Lee Ainslie’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-18,536	Closed	-$1.18M	–	237
2024 Q2	$1.18M	Buy	18,536 +13,926	+302%	+$904K	0.02%	197
2024 Q1	$319K	Buy	+4,610	New	+$278K	0.01%	338

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Lee Ainslie's ANIP Position: Q3 2024 in Review

Lee Ainslie sold out of ANI Pharmaceuticals (ANIP) in Q3 2024, closing a stake of 18,536 shares — an estimated $1.18M sold.

Lee Ainslie first reported a position in ANIP in Q1 2024 and held it in 2 quarters. The position peaked at $1.18M in Q2 2024. 208 funds tracked by Wall St. Rank hold ANIP as of Q3 2024.

Lee Ainslie reported no remaining ANI Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Lee Ainslie sold 18,536 ANI Pharmaceuticals shares in Q3 2024, an estimated $1.18M.
Lee Ainslie first reported a position in ANI Pharmaceuticals in Q1 2024 and held it in 2 quarters.
Lee Ainslie's ANI Pharmaceuticals position peaked at $1.18M in Q2 2024.
208 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2024.

Based on Maverick Capital's 13F filing for Q3 2024, filed 14 Nov 2024.